Blackmores Limited reports monster growth: What you need to know

The Blackmores Limited (ASX:BKL) share price has risen nearly five-fold since the beginning of 2015.

| More on:
a woman

You’re reading a free article with opinions that may differ from The Motley Fool’s Premium Investing Services. Become a Motley Fool member today to get instant access to our top analyst recommendations, in-depth research, investing resources, and more. Learn More

The Blackmores Limited (ASX: BKL) share price has risen more than 2% today after the vitamins business reported its half-year earnings results.

What Happened?

Indeed, Blackmores was one of the best performing shares on the ASX in 2015. From roughly $35 at the beginning of the year, the share price rose as much as 528% to a high of $220.90 on the back of soaring sales and earnings results. Shares have since pulled back, although they're still sitting almost five-times higher since the beginning of 2015 at $168.50.

Source: Yahoo! Finance – Blackmores' two-year share price chart
Source: Yahoo! Finance – Blackmores' two-year share price chart

The results released by the group today highlighted exactly why Australian investors fell in love with the shares. For the six-month period ended 31 December 2015, revenues rose 65.5% to $341.4 million, earnings before interest and tax (EBIT) rose 144.9% to $69.1 million (an EBIT margin of 20.2%) while net profit after tax (NPAT) soared 159.5% to $48.3 million.

It also ended the period with $42.9 million in cash versus $20 million in long-term debt and declared a $2 dividend per share (fully franked). That represents a 194% increase compared to the prior corresponding period.

At first glance, it appears that Australian sales accounted for most of Blackmores' growth during the period, given that sales rose 73% while EBIT more than doubled to $63.6 million. In a small note below those segment results however, the company said (emphasis added):"Australia segment revenue for the half-year ended 31 December 2015 includes the benefit of sales made to Australian customers which we believe are ultimately intended for Asian Markets."

While those sales to Asia were indirect, direct Asian sales also rose nearly 73% to $60.9 million with segment EBIT up 234%, albeit off a much lower base to $5.8 million.

Indeed, this growth is very exciting for shareholders of Blackmores, as well as those who own shares of Bellamy's Australia Ltd (ASX: BAL) and a2 Milk Company Ltd (Australia) (ASX: A2M). China is a huge market where demand is only expected to grow further for vitamins and baby formula, which Blackmores recently expanded into.

In saying that however, this is also a risk investors need to be aware of. As highlighted by The Australian Financial Review today, fund manager Geoff Wilson sold his shares of Blackmores and A2 Milk this week based on their vulnerability to a potential "crackdown" on 'grey market' sales in China. Grey market sales are those products which are purchased in Australia and then resold by consumers to Asian residents.

What happens now?

A crackdown is by no means guaranteed, but China may choose to do so in order to lower the risk of counterfeit products and the avoidance of duties. Of course, these companies also sell a lot of goods to China legitimately and those sales would presumably be safe, but indirect sales could still take a hit nonetheless.

This risk isn't a reason to avoid the shares like a plague, but investors certainly need to be cautious not to overexpose themselves in case it does come to fruition. As it is, the shares aren't cheap, per se, but are certainly worth keeping an eye on – particularly if the share price falls any further than its current level.

Motley Fool contributor Ryan Newman owns shares of Bellamy's Australia. Unless otherwise noted, the author does not have a position in any stocks mentioned by the author in the comments below. You can follow Ryan on Twitter @ASXvalueinvest. The Motley Fool Australia owns shares of Bellamy's Australia. We Fools may not all hold the same opinions, but we all believe that considering a diverse range of insights makes us better investors. The Motley Fool has a disclosure policy. This article contains general investment advice only (under AFSL 400691). Authorised by Bruce Jackson.

More on ⏸️ Investing

A white and black robot in the form of a human being stands in front of a green graphic holding a laptop and discussing robotics and automation ASX shares
Technology Shares

Joining the revolution: How I'd invest in ASX AI shares right now

Advances in artificial intelligence (AI) could usher in a new industrial revolution. Here’s how you can invest in it.

Read more »

Close up of baby looking puzzled
Retail Shares

What has happened to the Baby Bunting (ASX:BBN) share price this year?

It's been a volatile year so far for the Aussie nursery retailer. We take a closer look

Read more »

woman holds sign saying 'we need change' at climate change protest
ETFs

3 ASX ETFs that invest in companies fighting climate change

If you want to shift some of your investments into more ethical companies, exchange-traded funds can offer a good option

Read more »

a jewellery store attendant stands at a cabinet displaying opulent necklaces and earrings featuring diamonds and precious stones.
⏸️ Investing

The Michael Hill (ASX: MHJ) share price poised for growth

Investors will be keeping an eye on the Michael Hill International Limited (ASX: MHJ) share price today. The keen interest…

Read more »

ASX shares buy unstoppable asx share price represented by man in superman cape pointing skyward
⏸️ Investing

The Atomos (ASX:AMS) share price is up 15% in a week

The Atomos (ASX: AMS) share price has surged 15% this week. Let's look at what's ahead as the company build…

Read more »

Two people in suits arm wrestle on a black and white chess board.
Retail Shares

How does the Temple & Webster (ASX:TPW) share price stack up against Nick Scali (ASX:NCK)?

How does the Temple & Webster (ASX: TPW) share price stack up against rival furniture retailer Nick Scali Limited (ASX:…

Read more »

A medical researcher works on a bichip, indicating share price movement in ASX tech companies
Healthcare Shares

The Aroa (ASX:ARX) share price has surged 60% since its IPO

The Aroa (ASX:ARX) share price has surged 60% since the Polynovo (ASX: PNV) competitor listed on the ASX in July.…

Read more »

asx investor daydreaming about US shares
⏸️ How to Invest

How to buy US shares from Australia right now

If you have been wondering how to buy US shares from Australia to gain exposure from the highly topical market,…

Read more »